SCOPOLAMINE

SCOPOLAMINE was reported 3672 times

SCOPOLAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMOPHILUS SEPSIS 5 0.0877
1 RED BLOOD CELL ELLIPTOCYTES PRESENT 6 0.0779
2 IDEAS OF REFERENCE 7 0.0686
3 FAILURE TO SUSPEND MEDICATION 12 0.0580
4 ANTICHOLINERGIC EFFECT 4 0.0533
5 HYPERHOMOCYSTEINAEMIA 9 0.0344
6 ANISOCORIA 12 0.0317
7 ANTICHOLINERGIC SYNDROME 42 0.0263
8 DEAFNESS PERMANENT 5 0.0255
9 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 10 0.0238
10 MOTION SICKNESS 38 0.0197
11 MYDRIASIS 202 0.0157
12 FAECAL VOMITING 8 0.0150
13 FUNGAL OESOPHAGITIS 9 0.0128
14 BRONCHIAL SECRETION RETENTION 13 0.0102
15 TRACHEOBRONCHITIS 7 0.0091
16 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13 0.0089
17 APPLICATION SITE HYPERSENSITIVITY 10 0.0082
18 ACCIDENTAL DEATH 15 0.0081
19 APPLICATION SITE SCAR 10 0.0080
20 EPICONDYLITIS 12 0.0079
21 APPLICATION SITE DISCHARGE 9 0.0078
22 EMERGENCY CARE EXAMINATION 5 0.0074
23 TEMPERATURE REGULATION DISORDER 16 0.0072
24 PUPILS UNEQUAL 8 0.0070
25 INCISION SITE PAIN 8 0.0068
26 RENAL ARTERY STENOSIS 9 0.0065
27 MEAN CELL VOLUME DECREASED 10 0.0065
28 APPLICATION SITE BURN 29 0.0059
29 APPLICATION SITE IRRITATION 73 0.0059
30 INTESTINAL PSEUDO-OBSTRUCTION 5 0.0057
31 APPLICATION SITE ULCER 4 0.0056
32 INTRA-ABDOMINAL HAEMATOMA 7 0.0056
33 APPLICATION SITE REACTION 39 0.0055
34 ACCOMMODATION DISORDER 4 0.0055
35 TONGUE INJURY 5 0.0053
36 LOWER RESPIRATORY TRACT CONGESTION 9 0.0053
37 APPLICATION SITE INFLAMMATION 7 0.0051
38 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
39 APPLICATION SITE RASH 67 0.0049
40 CHRONIC GASTRITIS 11 0.0049
41 WHITE BLOOD CELLS URINE POSITIVE 9 0.0048
42 APPLICATION SITE PAPULES 5 0.0047
43 APTYALISM 4 0.0047
44 APPLICATION SITE EROSION 6 0.0047
45 APPLICATION SITE SCAB 10 0.0046
46 PUPIL FIXED 8 0.0046
47 MACULAR HOLE 6 0.0045
48 WRONG PATIENT RECEIVED PRODUCT 13 0.0044
49 APPLICATION SITE DERMATITIS 4 0.0043
50 TORTICOLLIS 9 0.0042
51 VOLVULUS 10 0.0042
52 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
53 DIASTOLIC DYSFUNCTION 13 0.0042
54 HIGH DENSITY LIPOPROTEIN DECREASED 14 0.0042
55 APPLICATION SITE URTICARIA 9 0.0040
56 APPLICATION SITE VESICLES 26 0.0040
57 ASTIGMATISM 6 0.0040
58 OSTEOSCLEROSIS 6 0.0038
59 APPLICATION SITE PRURITUS 86 0.0038
60 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 27 0.0038
61 APPLICATION SITE ERYTHEMA 98 0.0037
62 SALIVARY HYPERSECRETION 37 0.0037
63 TENOSYNOVITIS 10 0.0036
64 PORPHYRIA ACUTE 5 0.0035
65 GASTROINTESTINAL STROMAL TUMOUR 9 0.0034
66 CRANIOCEREBRAL INJURY 10 0.0033
67 APPLICATION SITE DRYNESS 11 0.0032
68 PERSECUTORY DELUSION 8 0.0032
69 IDIOPATHIC THROMBOCYTOPENIC PURPURA 5 0.0032
70 RADIOTHERAPY 6 0.0031
71 OVARIAN CANCER RECURRENT 5 0.0031
72 PRODUCT ADHESION ISSUE 111 0.0031
73 HYPERAEMIA 6 0.0030
74 PRE-EXISTING CONDITION IMPROVED 19 0.0030
75 GAZE PALSY 5 0.0029
76 TONGUE BITING 6 0.0029
77 DISORIENTATION 115 0.0029
78 MICROCYTIC ANAEMIA 6 0.0029
79 ANTIPSYCHOTIC DRUG LEVEL INCREASED 8 0.0028
80 VOCAL CORD PARALYSIS 5 0.0028
81 ANGLE CLOSURE GLAUCOMA 7 0.0027
82 ACUTE ABDOMEN 4 0.0027
83 FOETAL DEATH 14 0.0027
84 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
85 ASPIRATION 29 0.0026
86 SNORING 10 0.0026
87 HYPERNATRAEMIA 13 0.0026
88 APPLICATION SITE SWELLING 13 0.0026
89 NEPHROGENIC ANAEMIA 12 0.0026
90 APPLICATION SITE HAEMORRHAGE 7 0.0026
91 DRY MOUTH 205 0.0025
92 APHAGIA 12 0.0025
93 TRIGGER FINGER 10 0.0024
94 SCOLIOSIS 15 0.0024
95 NEUTROPENIC COLITIS 5 0.0024
96 STAPHYLOCOCCUS TEST POSITIVE 5 0.0024
97 APPLICATION SITE PAIN 52 0.0024
98 WITHDRAWAL SYNDROME 99 0.0024
99 CENTRAL VENOUS CATHETERISATION 7 0.0023
100 HALLUCINATION 174 0.0023
101 TRICUSPID VALVE INCOMPETENCE 18 0.0023
102 LIGAMENT RUPTURE 10 0.0023
103 BLOOD CREATININE DECREASED 7 0.0022
104 CLONUS 6 0.0022
105 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
106 BILIRUBIN CONJUGATED INCREASED 5 0.0021
107 ESCHERICHIA BACTERAEMIA 5 0.0021
108 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
109 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 115 0.0021
110 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
111 PNEUMONIA ASPIRATION 52 0.0021
112 INCORRECT DRUG ADMINISTRATION DURATION 58 0.0021
113 PRODUCT PACKAGING CONFUSION 5 0.0021
114 URINE ODOUR ABNORMAL 12 0.0020
115 VISION BLURRED 279 0.0020
116 HYPERREFLEXIA 7 0.0020
117 HYPERPARATHYROIDISM SECONDARY 5 0.0020
118 EMERGENCY CARE 6 0.0020
119 PATHOLOGICAL FRACTURE 10 0.0020
120 THERAPEUTIC RESPONSE UNEXPECTED 88 0.0020
121 ABDOMINAL INFECTION 5 0.0020
122 PORTAL HYPERTENSION 6 0.0019
123 FOOD ALLERGY 15 0.0019
124 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
125 ILEUS 24 0.0019
126 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
127 BLOOD PHOSPHORUS DECREASED 7 0.0019
128 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
129 ATRIAL TACHYCARDIA 4 0.0019
130 SKIN EROSION 6 0.0019
131 NEUTROPHIL COUNT INCREASED 19 0.0019
132 INCOHERENT 12 0.0019
133 BLOOD SODIUM INCREASED 5 0.0019
134 HYPOVENTILATION 6 0.0018
135 SPINAL OSTEOARTHRITIS 16 0.0018
136 VERTIGO 110 0.0018
137 METASTASES TO SPINE 6 0.0018
138 RESPIRATORY ACIDOSIS 7 0.0018
139 HIATUS HERNIA 23 0.0018
140 SWOLLEN TONGUE 55 0.0018
141 IMPAIRED DRIVING ABILITY 20 0.0018
142 DELIRIUM 61 0.0018
143 DERMATITIS CONTACT 20 0.0018
144 DROOLING 12 0.0017
145 ADENOVIRUS INFECTION 5 0.0017
146 ACUTE RESPIRATORY FAILURE 33 0.0017
147 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
148 HALLUCINATION, VISUAL 36 0.0017
149 APPLICATION SITE EXFOLIATION 7 0.0017
150 POLYP 11 0.0017
151 DRY THROAT 17 0.0017
152 ATELECTASIS 16 0.0017
153 FAECALOMA 9 0.0016
154 METASTASES TO CENTRAL NERVOUS SYSTEM 21 0.0016
155 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 10 0.0016
156 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
157 HYPERLIPIDAEMIA 19 0.0016
158 LYMPHOCYTE COUNT DECREASED 28 0.0016
159 KLEBSIELLA INFECTION 8 0.0016
160 RETCHING 33 0.0015
161 PRODUCT LABEL CONFUSION 9 0.0015
162 RHINOVIRUS INFECTION 6 0.0015
163 APNOEA 12 0.0015
164 FAILURE TO THRIVE 8 0.0015
165 AKATHISIA 21 0.0015
166 CONFUSIONAL STATE 243 0.0015
167 URINE OUTPUT DECREASED 13 0.0015
168 BRUXISM 8 0.0015
169 HYPOTHERMIA 15 0.0015
170 ENDOMETRIOSIS 7 0.0015
171 SMALL INTESTINAL OBSTRUCTION 18 0.0015
172 ACCIDENTAL EXPOSURE 6 0.0014
173 HYPOPNOEA 5 0.0014
174 PHOTOPHOBIA 27 0.0014
175 PROCEDURAL COMPLICATION 11 0.0014
176 INCORRECT DOSAGE ADMINISTERED 7 0.0014
177 DEVICE RELATED INFECTION 22 0.0014
178 COELIAC DISEASE 14 0.0014
179 HALLUCINATIONS, MIXED 6 0.0014
180 HANGOVER 5 0.0014
181 STAPHYLOCOCCAL SEPSIS 7 0.0014
182 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
183 FLUID INTAKE REDUCED 7 0.0014
184 HEPATIC LESION 6 0.0014
185 BONE LESION 5 0.0014
186 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
187 ARTERIOSCLEROSIS 13 0.0014
188 BLOOD UREA INCREASED 23 0.0014
189 DYSPHEMIA 6 0.0014
190 CACHEXIA 7 0.0014
191 CATHETERISATION CARDIAC 6 0.0014
192 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
193 HYPERACUSIS 5 0.0013
194 FEAR 36 0.0013
195 BLOOD CALCIUM DECREASED 15 0.0013
196 DYSPHONIA 78 0.0013
197 DRUG ADMINISTERED AT INAPPROPRIATE SITE 14 0.0013
198 SERUM FERRITIN INCREASED 7 0.0013
199 PRODUCT QUALITY ISSUE 180 0.0013
200 PNEUMOTHORAX 21 0.0013
201 UNRESPONSIVE TO STIMULI 34 0.0013
202 HAEMOGLOBIN INCREASED 6 0.0013
203 HAEMODYNAMIC INSTABILITY 10 0.0013
204 ANGIOEDEMA 58 0.0013
205 DIPLOPIA 34 0.0013
206 MUSCLE SPASTICITY 16 0.0013
207 AGITATION 95 0.0013
208 BEDRIDDEN 17 0.0013
209 COORDINATION ABNORMAL 18 0.0013
210 URINARY RETENTION 43 0.0013
211 MULTIPLE MYELOMA 6 0.0013
212 WOUND SECRETION 5 0.0013
213 NONSPECIFIC REACTION 7 0.0013
214 PNEUMONIA FUNGAL 5 0.0013
215 PRODUCT SUPPLY ISSUE 9 0.0013
216 BLOOD ALBUMIN DECREASED 10 0.0013
217 OBSTRUCTION 5 0.0013
218 TACHYPNOEA 17 0.0012
219 CYTOKINE RELEASE SYNDROME 25 0.0012
220 PREMATURE LABOUR 7 0.0012
221 BURSITIS 15 0.0012
222 APPLICATION SITE DISCOLOURATION 5 0.0012
223 RESTLESSNESS 45 0.0012
224 MENTAL STATUS CHANGES 34 0.0012
225 SPEECH DISORDER 64 0.0012
226 INTESTINAL OBSTRUCTION 46 0.0012
227 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
228 HYPERVOLAEMIA 6 0.0012
229 ENTEROCOLITIS 7 0.0012
230 ABDOMINAL TENDERNESS 6 0.0012
231 IMMUNODEFICIENCY 18 0.0012
232 METABOLIC DISORDER 7 0.0012
233 SEASONAL ALLERGY 17 0.0012
234 ANXIETY DISORDER 4 0.0012
235 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
236 HYPOXIA 42 0.0012
237 BACTERAEMIA 14 0.0012
238 BUNDLE BRANCH BLOCK LEFT 5 0.0012
239 DEFORMITY 11 0.0012
240 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
241 IMPAIRED GASTRIC EMPTYING 16 0.0012
242 LUNG NEOPLASM 5 0.0012
243 TRISMUS 6 0.0012
244 PARANOIA 20 0.0012
245 APLASTIC ANAEMIA 6 0.0011
246 HYPERCHOLESTEROLAEMIA 11 0.0011
247 BLOOD LACTIC ACID INCREASED 6 0.0011
248 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
249 RENAL CYST 9 0.0011
250 HALLUCINATION, AUDITORY 18 0.0011
251 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
252 PHYSICAL DISABILITY 5 0.0011
253 APHASIA 34 0.0011
254 IMPAIRED WORK ABILITY 24 0.0011
255 ASCITES 33 0.0011
256 MIOSIS 9 0.0011
257 SWELLING FACE 73 0.0011
258 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
259 INFUSION SITE SWELLING 7 0.0011
260 BLEPHAROSPASM 7 0.0011
261 SCAR 19 0.0011
262 DYSKINESIA 45 0.0011
263 DECUBITUS ULCER 9 0.0011
264 SEPTIC SHOCK 48 0.0011
265 VASCULAR DEVICE INFECTION 5 0.0011
266 BALANCE DISORDER 95 0.0011
267 ABDOMINAL HERNIA 5 0.0011
268 EAR DISORDER 5 0.0011
269 BLINDNESS TRANSIENT 8 0.0011
270 EYELID PTOSIS 11 0.0011
271 HYPOPHOSPHATAEMIA 8 0.0011
272 HYPERPROLACTINAEMIA 7 0.0011
273 INTERCEPTED MEDICATION ERROR 5 0.0011
274 CHOKING 21 0.0011
275 FEELING OF DESPAIR 5 0.0011
276 PERFORMANCE STATUS DECREASED 5 0.0011
277 VOMITING 501 0.0011
278 ACTIVITIES OF DAILY LIVING IMPAIRED 21 0.0011
279 VENTRICULAR EXTRASYSTOLES 11 0.0011
280 PERONEAL NERVE PALSY 6 0.0011
281 POST-TRAUMATIC STRESS DISORDER 7 0.0010
282 HYSTERECTOMY 9 0.0010
283 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
284 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
285 RALES 6 0.0010
286 DYSURIA 38 0.0010
287 DELUSION 16 0.0010
288 HYPOVOLAEMIA 6 0.0010
289 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
290 DECREASED INTEREST 6 0.0010
291 AMNESIA 66 0.0010
292 BREATH SOUNDS ABNORMAL 5 0.0010
293 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
294 ABASIA 25 0.0010
295 APHONIA 14 0.0010
296 TACHYCARDIA 89 0.0010
297 BLEPHARITIS 4 0.0010
298 HEPATITIS CHOLESTATIC 6 0.0010
299 DEHYDRATION 132 0.0010
300 MULTI-ORGAN FAILURE 17 0.0010
301 MALNUTRITION 11 0.0010
302 PRESCRIBED OVERDOSE 19 0.0010
303 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
304 MITRAL VALVE INCOMPETENCE 11 0.0010
305 FEBRILE NEUTROPENIA 64 0.0010
306 DISTURBANCE IN ATTENTION 52 0.0010
307 MAJOR DEPRESSION 7 0.0010
308 NASAL DRYNESS 6 0.0010
309 DYSARTHRIA 36 0.0010
310 SEDATION 25 0.0010
311 COLITIS 36 0.0009
312 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
313 CHOLELITHIASIS 31 0.0009
314 ABNORMAL BEHAVIOUR 37 0.0009
315 DYSPHAGIA 88 0.0009
316 BLOOD MAGNESIUM DECREASED 8 0.0009
317 HERPES SIMPLEX 6 0.0009
318 PARKINSONISM 9 0.0009
319 TROPONIN INCREASED 7 0.0009
320 SINUS TACHYCARDIA 13 0.0009
321 PSYCHOTIC DISORDER 27 0.0009
322 DIZZINESS 454 0.0009
323 DISABILITY 18 0.0009
324 TUMOUR LYSIS SYNDROME 8 0.0009
325 WRONG TECHNIQUE IN DRUG USAGE PROCESS 33 0.0009
326 RESPIRATORY DISTRESS 25 0.0009
327 CONCUSSION 7 0.0009
328 CARDIAC FAILURE ACUTE 6 0.0009
329 HYPOALBUMINAEMIA 7 0.0009
330 STEVENS-JOHNSON SYNDROME 20 0.0009
331 HYPERTENSIVE CRISIS 10 0.0009
332 NAUSEA 711 0.0009
333 COLITIS ISCHAEMIC 6 0.0009
334 HYPOKALAEMIA 41 0.0009
335 PLEURAL EFFUSION 54 0.0009
336 BRADYCARDIA 47 0.0009
337 HEAD INJURY 28 0.0009
338 DRUG TOXICITY 12 0.0009
339 ABSCESS 14 0.0009
340 EYE MOVEMENT DISORDER 6 0.0009
341 RENAL INJURY 26 0.0009
342 RETINAL DETACHMENT 8 0.0009
343 CORONARY ARTERY BYPASS 5 0.0009
344 PRODUCT COMPLAINT 22 0.0009
345 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
346 BLOOD POTASSIUM DECREASED 26 0.0009
347 ECONOMIC PROBLEM 13 0.0009
348 DYSSTASIA 25 0.0009
349 SPLENOMEGALY 10 0.0009
350 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
351 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
352 THERMAL BURN 6 0.0008
353 FEEDING DISORDER 17 0.0008
354 ANHEDONIA 22 0.0008
355 RESPIRATORY FAILURE 61 0.0008
356 PROTHROMBIN TIME PROLONGED 5 0.0008
357 POST PROCEDURAL COMPLICATION 16 0.0008
358 DRUG INTOLERANCE 80 0.0008
359 SINUS BRADYCARDIA 8 0.0008
360 MENTAL IMPAIRMENT 20 0.0008
361 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
362 HYPOPHAGIA 21 0.0008
363 HAEMORRHOIDS 16 0.0008
364 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15 0.0008
365 HYPERCALCAEMIA 10 0.0008
366 DRUG WITHDRAWAL SYNDROME 71 0.0008
367 GENERALISED OEDEMA 10 0.0008
368 SINUS DISORDER 16 0.0008
369 OLIGURIA 5 0.0008
370 ORTHOSTATIC HYPOTENSION 14 0.0008
371 NEUROTOXICITY 14 0.0008
372 EYE INFECTION 9 0.0008
373 REBOUND EFFECT 9 0.0008
374 LUNG INFILTRATION 7 0.0008
375 METASTASES TO BONE 13 0.0008
376 THERAPEUTIC RESPONSE CHANGED 5 0.0008
377 CHOLECYSTECTOMY 9 0.0008
378 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
379 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
380 SEROTONIN SYNDROME 15 0.0008
381 PERICARDIAL EFFUSION 18 0.0008
382 THROMBOCYTOPENIA 87 0.0008
383 OCCUPATIONAL EXPOSURE TO PRODUCT 5 0.0008
384 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
385 BLOOD BILIRUBIN INCREASED 21 0.0008
386 OROPHARYNGEAL DISCOMFORT 7 0.0008
387 PELVIC FRACTURE 6 0.0008
388 HEMIPARESIS 13 0.0008
389 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
390 BRAIN FOG 12 0.0008
391 IMPAIRED QUALITY OF LIFE 11 0.0008
392 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
393 WALKING AID USER 5 0.0008
394 CHOLECYSTITIS 9 0.0008
395 MUSCLE RIGIDITY 9 0.0008
396 HEPATIC STEATOSIS 14 0.0008
397 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
398 CHOLECYSTITIS CHRONIC 5 0.0007
399 FLANK PAIN 7 0.0007
400 WRONG PRODUCT ADMINISTERED 5 0.0007
401 INJURY 52 0.0007
402 PRODUCT USE IN UNAPPROVED INDICATION 183 0.0007
403 POST PROCEDURAL INFECTION 6 0.0007
404 PRODUCT LABEL ISSUE 5 0.0007
405 NEUTROPHIL COUNT DECREASED 30 0.0007
406 HEAD DISCOMFORT 13 0.0007
407 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
408 ENCEPHALOPATHY 18 0.0007
409 RENAL FAILURE ACUTE 31 0.0007
410 HYPONATRAEMIA 41 0.0007
411 THIRST 13 0.0007
412 SPINAL COMPRESSION FRACTURE 6 0.0007
413 LARGE INTESTINE POLYP 5 0.0007
414 DYSTONIA 14 0.0007
415 COAGULOPATHY 12 0.0007
416 GASTROENTERITIS VIRAL 13 0.0007
417 FORMICATION 5 0.0007
418 LEUKOCYTOSIS 13 0.0007
419 HYPOMAGNESAEMIA 10 0.0007
420 DEMENTIA 20 0.0007
421 RIGHT VENTRICULAR FAILURE 5 0.0007
422 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
423 OCULAR DISCOMFORT 8 0.0007
424 HEART RATE DECREASED 25 0.0007
425 SEIZURE 82 0.0007
426 SKIN REACTION 10 0.0007
427 HOSPICE CARE 7 0.0007
428 LIGAMENT SPRAIN 7 0.0007
429 EATING DISORDER 15 0.0007
430 FACIAL PARALYSIS 6 0.0007
431 SOMNOLENCE 141 0.0007
432 NEUTROPENIC SEPSIS 5 0.0007
433 HYPERSOMNIA 20 0.0007
434 OFF LABEL USE 609 0.0007
435 PYELONEPHRITIS 6 0.0007
436 EYE PAIN 39 0.0007
437 BLOOD SODIUM DECREASED 13 0.0007
438 NODULE 9 0.0007
439 MOTOR DYSFUNCTION 7 0.0007
440 BODY TEMPERATURE INCREASED 14 0.0007
441 GROIN PAIN 6 0.0007
442 METASTASES TO LIVER 12 0.0007
443 ORAL DISORDER 5 0.0007
444 URINARY TRACT INFECTION 116 0.0007
445 HYPERSENSITIVITY 126 0.0007
446 LIMB DISCOMFORT 21 0.0007
447 LETHARGY 39 0.0007
448 VISUAL IMPAIRMENT 84 0.0007
449 URINARY INCONTINENCE 20 0.0007
450 FEELING DRUNK 5 0.0007
451 TENDERNESS 7 0.0007
452 RASH ERYTHEMATOUS 32 0.0007
453 WEIGHT FLUCTUATION 7 0.0007
454 HYDRONEPHROSIS 5 0.0007
455 HEART RATE IRREGULAR 15 0.0007
456 VIRAL INFECTION 22 0.0007
457 STOMATITIS 40 0.0007
458 CYSTITIS 21 0.0007
459 BONE DISORDER 12 0.0007
460 END STAGE RENAL DISEASE 12 0.0007
461 DRUG INTERACTION 104 0.0007
462 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
463 CARDIOMEGALY 8 0.0006
464 DECREASED ACTIVITY 7 0.0006
465 PHARYNGITIS STREPTOCOCCAL 7 0.0006
466 CARDIO-RESPIRATORY ARREST 27 0.0006
467 BLOOD CREATININE INCREASED 42 0.0006
468 COGNITIVE DISORDER 30 0.0006
469 ANXIETY 182 0.0006
470 BLINDNESS UNILATERAL 9 0.0006
471 MULTIPLE ALLERGIES 5 0.0006
472 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
473 BRAIN OEDEMA 8 0.0006
474 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 45 0.0006
475 HYPERGLYCAEMIA 23 0.0006
476 FEELING ABNORMAL 151 0.0006
477 SLEEP APNOEA SYNDROME 12 0.0006
478 PARALYSIS 9 0.0006
479 MIGRAINE 60 0.0006
480 SEPSIS 70 0.0006
481 INTRAOCULAR PRESSURE INCREASED 8 0.0006
482 PNEUMONITIS 17 0.0006
483 COLD SWEAT 11 0.0006
484 BRONCHITIS 46 0.0006
485 INFUSION SITE PAIN 8 0.0006
486 CARDIAC ARREST 51 0.0006
487 EAR PAIN 12 0.0006
488 GALLBLADDER DISORDER 11 0.0006
489 RENAL TUBULAR NECROSIS 6 0.0006
490 MUCOSAL INFLAMMATION 16 0.0006
491 HEPATOMEGALY 6 0.0006
492 PLATELET COUNT DECREASED 65 0.0006
493 FLUID RETENTION 31 0.0006
494 ASPERGILLUS INFECTION 4 0.0006
495 PANCYTOPENIA 34 0.0006
496 ESCHERICHIA INFECTION 5 0.0006
497 MUSCLE TWITCHING 14 0.0006
498 METASTASES TO LUNG 7 0.0006
499 PHOTOSENSITIVITY REACTION 10 0.0006
500 CONSTIPATION 132 0.0006
501 ELECTROLYTE IMBALANCE 7 0.0006
502 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 122 0.0006
503 DRY EYE 30 0.0006
504 PAIN IN JAW 17 0.0006
505 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
506 CELLULITIS 30 0.0006
507 EMPHYSEMA 6 0.0006
508 RED BLOOD CELL COUNT DECREASED 17 0.0006
509 SKIN PLAQUE 5 0.0006
510 TASTE DISORDER 12 0.0006
511 ABDOMINAL PAIN 137 0.0006
512 COMA 28 0.0006
513 BLOOD PRESSURE DECREASED 39 0.0006
514 ALANINE AMINOTRANSFERASE INCREASED 36 0.0006
515 INITIAL INSOMNIA 6 0.0006
516 HEADACHE 366 0.0006
517 RIB FRACTURE 12 0.0006
518 CARDIAC OPERATION 5 0.0006
519 HYPOCALCAEMIA 11 0.0006
520 ANURIA 5 0.0006
521 PULMONARY OEDEMA 26 0.0006
522 ORAL PAIN 13 0.0006
523 FOOT FRACTURE 11 0.0006
524 RENAL FAILURE 77 0.0006
525 LUNG INFECTION 9 0.0006
526 ADVERSE DRUG REACTION 52 0.0006
527 MUSCLE STRAIN 5 0.0006
528 NERVOUS SYSTEM DISORDER 18 0.0006
529 PANIC ATTACK 21 0.0006
530 NEURALGIA 14 0.0006
531 MALAISE 252 0.0006
532 NO THERAPEUTIC RESPONSE 7 0.0006
533 HYPOTENSION 115 0.0006
534 TRANSFUSION 6 0.0006
535 PRODUCT AVAILABILITY ISSUE 13 0.0006
536 GASTRITIS 15 0.0006
537 DECREASED APPETITE 132 0.0006
538 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
539 SKIN IRRITATION 26 0.0006
540 SUDDEN DEATH 6 0.0006
541 TREMOR 94 0.0006
542 PRODUCTIVE COUGH 27 0.0006
543 SCIATICA 9 0.0006
544 EAR INFECTION 15 0.0006
545 WHITE BLOOD CELL COUNT DECREASED 61 0.0006
546 FACIAL PAIN 5 0.0006
547 SECRETION DISCHARGE 7 0.0006
548 GASTROINTESTINAL INFECTION 5 0.0006
549 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13 0.0006
550 ANAL INCONTINENCE 5 0.0006
551 DRUG ADMINISTRATION ERROR 17 0.0006
552 MENTAL DISORDER 24 0.0006
553 OROPHARYNGEAL PAIN 51 0.0006
554 CRYING 20 0.0005
555 WOUND INFECTION 6 0.0005
556 EXOSTOSIS 5 0.0005
557 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
558 NEOPLASM PROGRESSION 19 0.0005
559 LOSS OF CONSCIOUSNESS 70 0.0005
560 VENTRICULAR TACHYCARDIA 9 0.0005
561 NEPHROLITHIASIS 25 0.0005
562 TINNITUS 25 0.0005
563 ANOREXIA 7 0.0005
564 OSTEOARTHRITIS 23 0.0005
565 UNEVALUABLE EVENT 41 0.0005
566 IRON DEFICIENCY ANAEMIA 5 0.0005
567 NERVE INJURY 6 0.0005
568 PRODUCT DISTRIBUTION ISSUE 5 0.0005
569 GAIT INABILITY 18 0.0005
570 PLASMA CELL MYELOMA 21 0.0005
571 HAEMOGLOBIN DECREASED 55 0.0005
572 HYPERHIDROSIS 69 0.0005
573 SKIN INFECTION 6 0.0005
574 FIBROMYALGIA 13 0.0005
575 INTESTINAL PERFORATION 6 0.0005
576 WEIGHT DECREASED 149 0.0005
577 FISTULA 6 0.0005
578 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
579 ORAL CANDIDIASIS 7 0.0005
580 STATUS EPILEPTICUS 6 0.0005
581 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
582 SPUTUM DISCOLOURED 5 0.0005
583 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
584 ACIDOSIS 4 0.0005
585 WHEEZING 31 0.0005
586 MALIGNANT MELANOMA 7 0.0005
587 JOINT RANGE OF MOTION DECREASED 7 0.0005
588 CHOLESTASIS 10 0.0005
589 DRUG PRESCRIBING ERROR 10 0.0005
590 PHARYNGEAL OEDEMA 8 0.0005
591 MEMORY IMPAIRMENT 71 0.0005
592 OXYGEN SATURATION DECREASED 29 0.0005
593 PARAESTHESIA 81 0.0005
594 FALL 171 0.0005
595 ACUTE MYELOID LEUKAEMIA 8 0.0005
596 POOR QUALITY SLEEP 11 0.0005
597 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
598 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
599 VITREOUS FLOATERS 5 0.0005
600 DEEP VEIN THROMBOSIS 33 0.0005
601 PRODUCT USE COMPLAINT 8 0.0005
602 PNEUMONIA 164 0.0005
603 PULMONARY EMBOLISM 48 0.0005
604 HAEMATOCRIT DECREASED 10 0.0005
605 BLADDER DISORDER 5 0.0005
606 BLOOD PRESSURE ABNORMAL 10 0.0005
607 SKIN ULCER 13 0.0005
608 INTENTIONAL PRODUCT MISUSE 44 0.0005
609 PREMATURE DELIVERY 8 0.0005
610 CHRONIC KIDNEY DISEASE 38 0.0005
611 NEUTROPENIA 68 0.0005
612 BLOOD PRESSURE FLUCTUATION 12 0.0005
613 BLISTER 28 0.0005
614 MOVEMENT DISORDER 16 0.0005
615 ABDOMINAL DISTENSION 52 0.0005
616 TOXICITY TO VARIOUS AGENTS 84 0.0005
617 CHEST DISCOMFORT 51 0.0005
618 TRANSAMINASES INCREASED 11 0.0005
619 HEPATOTOXICITY 11 0.0005
620 ANAEMIA 94 0.0005
621 HYPERTENSION 104 0.0005
622 BLINDNESS 20 0.0005
623 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
624 HYPERKALAEMIA 17 0.0005
625 TEMPERATURE INTOLERANCE 5 0.0005
626 MYELODYSPLASTIC SYNDROME 7 0.0005
627 HYPERBILIRUBINAEMIA 5 0.0005
628 HAIR COLOUR CHANGES 6 0.0005
629 MIDDLE INSOMNIA 9 0.0005
630 VISUAL ACUITY REDUCED 16 0.0005
631 FREQUENT BOWEL MOVEMENTS 13 0.0005
632 LEUKOPENIA 24 0.0005
633 GASTROENTERITIS 7 0.0005
634 HEPATIC CIRRHOSIS 9 0.0005
635 SURGERY 28 0.0005
636 PYREXIA 165 0.0005
637 OEDEMA PERIPHERAL 58 0.0005
638 FACE OEDEMA 8 0.0005
639 MUSCLE ATROPHY 6 0.0005
640 INCONTINENCE 5 0.0005
641 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
642 CONVULSION 27 0.0005
643 PULMONARY MASS 7 0.0005
644 BODY HEIGHT DECREASED 5 0.0005
645 GLAUCOMA 9 0.0005
646 MUSCULAR WEAKNESS 53 0.0005
647 HERNIA 9 0.0005
648 GAIT DISTURBANCE 89 0.0005
649 LACRIMATION INCREASED 14 0.0005
650 PRODUCT USE ISSUE 87 0.0005
651 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
652 PLATELET COUNT INCREASED 6 0.0005
653 SKIN LACERATION 5 0.0005
654 MALIGNANT NEOPLASM PROGRESSION 47 0.0005
655 KIDNEY INFECTION 9 0.0005
656 SINUSITIS 47 0.0005
657 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
658 IMMUNE SYSTEM DISORDER 6 0.0005
659 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
660 ASTHENIA 171 0.0005
661 STAPHYLOCOCCAL INFECTION 15 0.0005
662 GASTROINTESTINAL PAIN 5 0.0005
663 CHEST PAIN 84 0.0005
664 DYSMENORRHOEA 6 0.0005
665 PALPITATIONS 53 0.0005
666 ADVERSE REACTION 6 0.0005
667 NEUROPATHY PERIPHERAL 43 0.0005
668 DENTAL CARIES 5 0.0005
669 FUNGAL INFECTION 15 0.0004
670 ILLNESS 46 0.0004
671 JAUNDICE 12 0.0004
672 THROAT IRRITATION 20 0.0004
673 OSTEONECROSIS OF JAW 11 0.0004
674 ILL-DEFINED DISORDER 27 0.0004
675 ACUTE KIDNEY INJURY 68 0.0004
676 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
677 PALLOR 12 0.0004
678 AGEUSIA 11 0.0004
679 RESPIRATORY TRACT CONGESTION 7 0.0004
680 C-REACTIVE PROTEIN INCREASED 16 0.0004
681 OBESITY 7 0.0004
682 MYOCARDIAL ISCHAEMIA 5 0.0004
683 EMOTIONAL DISTRESS 53 0.0004
684 PERIPHERAL COLDNESS 6 0.0004
685 SENSORY DISTURBANCE 7 0.0004
686 RESPIRATORY ARREST 12 0.0004
687 INFECTION 63 0.0004
688 PANCREATITIS 23 0.0004
689 ORAL DISCOMFORT 6 0.0004
690 BACK DISORDER 7 0.0004
691 AGRANULOCYTOSIS 8 0.0004
692 INFLUENZA 48 0.0004
693 HAEMOPTYSIS 12 0.0004
694 POST PROCEDURAL HAEMORRHAGE 5 0.0004
695 THINKING ABNORMAL 8 0.0004
696 MASS 6 0.0004
697 LUNG DISORDER 21 0.0004
698 SPINAL PAIN 5 0.0004
699 DEVICE OCCLUSION 6 0.0004
700 EYE DISORDER 14 0.0004
701 HEPATOCELLULAR INJURY 6 0.0004
702 DRUG LEVEL INCREASED 7 0.0004
703 ARRHYTHMIA 20 0.0004
704 RESPIRATORY TRACT INFECTION 11 0.0004
705 OVERDOSE 91 0.0004
706 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
707 NERVOUSNESS 22 0.0004
708 SYNCOPE 42 0.0004
709 CARDIOGENIC SHOCK 6 0.0004
710 BACK PAIN 97 0.0004
711 MEDICATION ERROR 23 0.0004
712 SKIN DISCOLOURATION 19 0.0004
713 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
714 GASTROINTESTINAL DISORDER 37 0.0004
715 SCHIZOPHRENIA 5 0.0004
716 SKIN FISSURES 8 0.0004
717 HAEMATURIA 14 0.0004
718 COUGH 114 0.0004
719 OEDEMA 22 0.0004
720 LIMB INJURY 11 0.0004
721 RENAL IMPAIRMENT 34 0.0004
722 EYE SWELLING 15 0.0004
723 PHARYNGITIS 5 0.0004
724 HAEMORRHAGE INTRACRANIAL 6 0.0004
725 SNEEZING 9 0.0004
726 CHILLS 47 0.0004
727 HYPOAESTHESIA 60 0.0004
728 CHROMATURIA 9 0.0004
729 HEPATIC ENZYME INCREASED 27 0.0004
730 OSTEOPENIA 6 0.0004
731 EPILEPSY 12 0.0004
732 PAIN 241 0.0004
733 INFUSION RELATED REACTION 26 0.0004
734 DIARRHOEA 252 0.0004
735 SKIN DISORDER 13 0.0004
736 TOOTH LOSS 8 0.0004
737 FATIGUE 300 0.0004
738 RESTLESS LEGS SYNDROME 7 0.0004
739 ACCIDENTAL OVERDOSE 14 0.0004
740 SUICIDAL IDEATION 35 0.0004
741 ECZEMA 20 0.0004
742 CYANOSIS 6 0.0004
743 ASTHMA 43 0.0004
744 ATRIAL FIBRILLATION 37 0.0004
745 PRODUCT PRESCRIBING ERROR 9 0.0004
746 DISCOMFORT 23 0.0004
747 DYSPEPSIA 37 0.0004
748 HYPOTHYROIDISM 12 0.0004
749 LIVER FUNCTION TEST INCREASED 8 0.0004
750 LOCALISED INFECTION 9 0.0004
751 MUSCLE TIGHTNESS 6 0.0004
752 EXPOSURE DURING PREGNANCY 23 0.0004
753 BLOOD POTASSIUM INCREASED 6 0.0004
754 ABDOMINAL PAIN UPPER 76 0.0004
755 FAECES DISCOLOURED 8 0.0004
756 RESPIRATORY DISORDER 11 0.0004
757 DYSPNOEA 207 0.0004
758 RENAL DISORDER 17 0.0004
759 MANIA 6 0.0004
760 HEART RATE INCREASED 36 0.0004
761 CEREBRAL HAEMORRHAGE 13 0.0004
762 ABNORMAL DREAMS 10 0.0004
763 ORAL HERPES 7 0.0004
764 OCULAR HYPERAEMIA 17 0.0004
765 NECK PAIN 20 0.0004
766 INSOMNIA 95 0.0004
767 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
768 BLOOD TEST ABNORMAL 5 0.0004
769 CANDIDA INFECTION 6 0.0004
770 HAEMATEMESIS 9 0.0004
771 ANGER 12 0.0004
772 GENERAL PHYSICAL HEALTH DETERIORATION 41 0.0004
773 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
774 RASH 154 0.0004
775 SUBDURAL HAEMATOMA 5 0.0003
776 ANAPHYLACTIC SHOCK 9 0.0003
777 FULL BLOOD COUNT DECREASED 7 0.0003
778 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
779 PARAESTHESIA ORAL 5 0.0003
780 HOT FLUSH 26 0.0003
781 HOSPITALISATION 53 0.0003
782 BONE MARROW FAILURE 7 0.0003
783 HAEMATOCHEZIA 19 0.0003
784 METABOLIC ACIDOSIS 11 0.0003
785 RASH MACULAR 12 0.0003
786 BURNING SENSATION 24 0.0003
787 LACTIC ACIDOSIS 11 0.0003
788 LYMPHADENOPATHY 12 0.0003
789 ATAXIA 4 0.0003
790 DYSGEUSIA 25 0.0003
791 ISCHAEMIC STROKE 6 0.0003
792 PULMONARY HYPERTENSION 7 0.0003
793 COLON CANCER 5 0.0003
794 CONDITION AGGRAVATED 102 0.0003
795 TOOTHACHE 6 0.0003
796 OSTEOMYELITIS 6 0.0003
797 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
798 ADRENAL INSUFFICIENCY 4 0.0003
799 DISEASE PROGRESSION 39 0.0003
800 JOINT INJURY 7 0.0003
801 INSURANCE ISSUE 5 0.0003
802 LIVER INJURY 8 0.0003
803 PAIN IN EXTREMITY 96 0.0003
804 DEPRESSION 74 0.0003
805 FLUSHING 33 0.0003
806 PERIPHERAL SWELLING 50 0.0003
807 CARDIAC FAILURE 26 0.0003
808 TARDIVE DYSKINESIA 9 0.0003
809 MELAENA 7 0.0003
810 NIGHTMARE 11 0.0003
811 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
812 DRUG DEPENDENCE 51 0.0003
813 ABDOMINAL PAIN LOWER 8 0.0003
814 BLOOD URINE PRESENT 6 0.0003
815 LIVER DISORDER 14 0.0003
816 GASTRIC ULCER 6 0.0003
817 PROTEINURIA 6 0.0003
818 FEELING JITTERY 6 0.0003
819 ANGINA PECTORIS 9 0.0003
820 INCREASED APPETITE 6 0.0003
821 COLITIS ULCERATIVE 14 0.0003
822 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 56 0.0003
823 INFLAMMATION 16 0.0003
824 LIVER FUNCTION TEST ABNORMAL 9 0.0003
825 CEREBROVASCULAR ACCIDENT 52 0.0003
826 MULTIPLE SCLEROSIS RELAPSE 21 0.0003
827 MUSCLE SPASMS 56 0.0003
828 OSTEONECROSIS 10 0.0003
829 DIABETES MELLITUS 23 0.0003
830 ACCIDENTAL EXPOSURE TO PRODUCT 31 0.0003
831 FLATULENCE 17 0.0003
832 HEPATIC FAILURE 9 0.0003
833 DEATH 257 0.0003
834 CORONARY ARTERY DISEASE 9 0.0003
835 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
836 THROAT TIGHTNESS 8 0.0003
837 INJURY ASSOCIATED WITH DEVICE 6 0.0003
838 BLOOD PRESSURE INCREASED 45 0.0003
839 DISEASE RECURRENCE 14 0.0003
840 NASOPHARYNGITIS 54 0.0003
841 MOBILITY DECREASED 21 0.0003
842 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
843 MUSCULOSKELETAL DISCOMFORT 5 0.0003
844 THERAPY NON-RESPONDER 13 0.0003
845 DIVERTICULITIS 8 0.0003
846 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
847 ROAD TRAFFIC ACCIDENT 12 0.0003
848 EOSINOPHILIA 5 0.0003
849 MOUTH ULCERATION 6 0.0003
850 SKIN EXFOLIATION 24 0.0003
851 INTENTIONAL DOSE OMISSION 8 0.0003
852 INFLUENZA LIKE ILLNESS 23 0.0003
853 SKIN CANCER 6 0.0003
854 SWELLING 26 0.0003
855 PRURITUS GENERALISED 6 0.0003
856 ERYTHEMA 57 0.0003
857 DRY SKIN 37 0.0003
858 DEVICE LEAKAGE 12 0.0003
859 ANOSMIA 4 0.0003
860 CARDIOVASCULAR DISORDER 7 0.0003
861 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
862 HEPATITIS 7 0.0003
863 ANAPHYLACTIC REACTION 15 0.0003
864 EXPIRED PRODUCT ADMINISTERED 9 0.0003
865 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
866 HAEMATOMA 7 0.0003
867 BACTERIAL INFECTION 5 0.0003
868 HEPATIC FUNCTION ABNORMAL 10 0.0003
869 RASH PAPULAR 6 0.0003
870 LUNG NEOPLASM MALIGNANT 11 0.0003
871 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
872 IRRITABILITY 16 0.0003
873 TREATMENT FAILURE 22 0.0003
874 JOINT SWELLING 32 0.0003
875 DRUG INEFFECTIVE 346 0.0003
876 ABDOMINAL DISCOMFORT 44 0.0003
877 SHOCK 6 0.0003
878 PAIN OF SKIN 7 0.0003
879 AGGRESSION 13 0.0003
880 CONTUSION 25 0.0003
881 EMOTIONAL DISORDER 8 0.0003
882 ERUCTATION 5 0.0003
883 ANKLE FRACTURE 4 0.0003
884 HAEMORRHAGE 27 0.0003
885 PRURITUS 99 0.0003
886 BLOOD CHOLESTEROL INCREASED 12 0.0003
887 COVID-19 45 0.0003
888 BASAL CELL CARCINOMA 4 0.0003
889 RECTAL HAEMORRHAGE 11 0.0003
890 HYPOACUSIS 11 0.0003
891 MENORRHAGIA 5 0.0003
892 CATARACT 15 0.0003
893 FEELING COLD 7 0.0003
894 PRESCRIBED UNDERDOSE 5 0.0003
895 ARTHRALGIA 104 0.0002
896 BLOOD GLUCOSE DECREASED 12 0.0002
897 ABORTION SPONTANEOUS 10 0.0002
898 NIGHT SWEATS 8 0.0002
899 PRODUCT PHYSICAL ISSUE 5 0.0002
900 INTENTIONAL SELF-INJURY 5 0.0002
901 PRODUCT ADMINISTRATION ERROR 5 0.0002
902 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
903 PRESYNCOPE 6 0.0002
904 WEIGHT INCREASED 55 0.0002
905 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
906 OSTEOPOROSIS 10 0.0002
907 EXTRAPYRAMIDAL DISORDER 6 0.0002
908 PRODUCT DOSE OMISSION ISSUE 71 0.0002
909 PERITONITIS 5 0.0002
910 SLEEP DISORDER 17 0.0002
911 POLLAKIURIA 10 0.0002
912 NEOPLASM MALIGNANT 16 0.0002
913 DYSPNOEA EXERTIONAL 9 0.0002
914 NASAL CONGESTION 14 0.0002
915 EYE PRURITUS 8 0.0002
916 TREATMENT NONCOMPLIANCE 13 0.0002
917 CARDIAC FAILURE CONGESTIVE 19 0.0002
918 THROMBOSIS 19 0.0002
919 IRRITABLE BOWEL SYNDROME 5 0.0002
920 SUICIDE ATTEMPT 14 0.0002
921 PRODUCT PRESCRIBING ISSUE 5 0.0002
922 MYALGIA 39 0.0002
923 MUSCULOSKELETAL STIFFNESS 20 0.0002
924 DEPRESSED MOOD 12 0.0002
925 HERPES ZOSTER 13 0.0002
926 FEMUR FRACTURE 7 0.0002
927 EYE IRRITATION 13 0.0002
928 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
929 PANCREATITIS ACUTE 5 0.0002
930 EXTRA DOSE ADMINISTERED 9 0.0002
931 URTICARIA 37 0.0002
932 MOOD SWINGS 7 0.0002
933 HIP FRACTURE 7 0.0002
934 PROCEDURAL PAIN 6 0.0002
935 ARTHROPATHY 12 0.0002
936 RHABDOMYOLYSIS 9 0.0002
937 RHEUMATOID ARTHRITIS 24 0.0002
938 THERAPY INTERRUPTED 15 0.0002
939 PRODUCT SUBSTITUTION ISSUE 12 0.0002
940 TYPE 2 DIABETES MELLITUS 7 0.0002
941 INCORRECT DOSE ADMINISTERED 47 0.0002
942 UNDERDOSE 15 0.0002
943 BONE PAIN 12 0.0002
944 GASTRIC DISORDER 7 0.0002
945 ARTHRITIS 16 0.0002
946 LABORATORY TEST ABNORMAL 6 0.0002
947 EPISTAXIS 15 0.0002
948 GASTRIC CANCER 5 0.0002
949 FEELING HOT 12 0.0002
950 CARDIAC DISORDER 18 0.0002
951 BONE DENSITY DECREASED 6 0.0002
952 DEAFNESS 5 0.0002
953 INTERSTITIAL LUNG DISEASE 9 0.0002
954 RHINORRHOEA 12 0.0002
955 DRUG EFFECT DECREASED 10 0.0002
956 HYPOGLYCAEMIA 9 0.0002
957 ACNE 14 0.0002
958 MOOD ALTERED 5 0.0002
959 WOUND 5 0.0002
960 BLOOD GLUCOSE INCREASED 33 0.0002
961 ADVERSE EVENT 16 0.0002
962 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
963 RASH PRURITIC 9 0.0002
964 VAGINAL HAEMORRHAGE 7 0.0002
965 DEVICE DISLOCATION 7 0.0002
966 DEVICE ISSUE 14 0.0002
967 THERAPY CESSATION 8 0.0002
968 PSORIASIS 20 0.0002
969 MUSCULOSKELETAL PAIN 8 0.0002
970 IMPAIRED HEALING 5 0.0002
971 ALOPECIA 29 0.0001
972 DEVICE USE ERROR 5 0.0001
973 SKIN BURNING SENSATION 10 0.0001
974 BREAST CANCER 13 0.0001
975 DRUG EFFECT INCOMPLETE 5 0.0001
976 ACUTE MYOCARDIAL INFARCTION 4 0.0001
977 INJECTION SITE MASS 5 0.0001
978 MULTIPLE SCLEROSIS 6 0.0001
979 MYOCARDIAL INFARCTION 21 0.0001
980 THERAPEUTIC RESPONSE DECREASED 7 0.0001
981 PRODUCT STORAGE ERROR 10 0.0001
982 COMPLETED SUICIDE 9 0.0001
983 DERMATITIS ATOPIC 5 0.0001
984 INTENTIONAL OVERDOSE 6 0.0001
985 PRODUCT DOSE OMISSION 6 0.0001
986 INJECTION SITE REACTION 6 0.0001
987 DRUG ABUSE 7 0.0001
988 INJECTION SITE PAIN 23 0.0001
989 PROSTATE CANCER 6 0.0001
990 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
991 DEVICE MALFUNCTION 5 0.0001
992 DRUG DOSE OMISSION 11 0.0001
993 INJECTION SITE BRUISING 5 0.0001
994 INJECTION SITE ERYTHEMA 5 0.0000